Harbour Investments’s Soleno Therapeutics SLNO Stock Holding History

Harbour Investments’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-74	Closed	-$2.48K	–	4869
2026 Q1	$2.48K	Buy	+74	New	+$2.9K	﹤0.01%	3847
2024 Q2	–	Sell	-5	Closed	-$214	–	3364
2024 Q1	$214	Hold	5	–	–	﹤0.01%	3108
2023 Q4	$201	Buy	+5	New	+$142	﹤0.01%	3009

Harbour Investments's SLNO Position: Q2 2026 in Review

Harbour Investments sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 74 shares — an estimated $2.48K sold.

Harbour Investments first reported a position in SLNO in Q4 2023 and held it in 3 quarters. The position peaked at $2.48K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Harbour Investments reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Harbour Investments sold 74 Soleno Therapeutics shares in Q2 2026, an estimated $2.48K.
Harbour Investments first reported a position in Soleno Therapeutics in Q4 2023 and held it in 3 quarters.
Harbour Investments's Soleno Therapeutics position peaked at $2.48K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.